← Back to All Filings

Jazz Pharmaceuticals Director Laura Hamill Disposes Shares for Tax Obligations

Low SignificanceSeptember 2, 2026 at 9:38:32 PM UTC

Jazz Pharmaceuticals plc

$JAZZ4CIK: 0001232524

Subscribe to track JAZZ

Premium users can add ticker alerts and receive realtime notification updates.

Filing Summary

📊 Form 4 Filing Alert: Jazz Pharmaceuticals plc ($JAZZ) Insider: Hamill Laura (Director) Transaction Type: Tax Withholding (Code F) Shares Transacted: 1,706 ordinary shares Average Price: ~$241.41 Total Value: $411,848.78 Shares Held After: 6,832 Significance: Low (Mandatory tax withholding from RSU vesting)

Comprehensive Analysis

Insider Transaction Summary

Reporting Owner: Laura Hamill
Role: Director
Issuer: Jazz Pharmaceuticals plc (JAZZ)
Filing Date: September 2, 2026
Transaction Date: August 31, 2026


Transaction Breakdown

Laura Hamill reported two non-derivative dispositions of Ordinary Shares on August 31, 2026, executed under transaction code F:

  • Transaction 1: 14 Ordinary Shares disposed at $244.0643 per share.

  • Transaction 2: 1,692 Ordinary Shares disposed at $241.39 per share.

  • Total Shares Disposed: 1,706

  • Aggregate Consideration: ~$411,848.78

  • Remaining Direct Holdings: 6,832 Ordinary Shares


Context & Trading Significance

According to footnote disclosure [F1], the shares were surrendered/sold solely to satisfy tax withholding obligations triggered by the vesting of previously granted Restricted Stock Units (RSUs). Because these transactions are administrative, non-discretionary, and tied directly to routine equity compensation vesting schedules rather than open-market buying or selling decisions, the trading significance of this filing is categorized as Low.

Topics:#JAZZ#JazzPharmaceuticals#SECForm4#InsiderTrading#Biotech

Get Real-Time Alerts

Join our community to receive instant notifications when high-significance filings are published

Important Disclaimer

This content is AI-generated from public SEC filings and may contain errors. It is for informational and educational purposes only and is not investment, legal, or tax advice.

The Filing Fool is not a registered investment adviser, broker-dealer, or financial planner. Nothing here is a recommendation or solicitation to buy, sell, or hold any security.

Always do your own due diligence and consult a licensed professional.